Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value
$157.64M
Total Bought
$1.03M
Total Sold
$66.38M
Net Transaction
-$65.35M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
AMARIN CORP PLC1,673,3951,673,395023,35224,19715.35%+845
LANTHEUS HLDGS INC(LNTH)181,450166,919-14,53112,07512,6618.03%+585
VOR BIOPHARMA INC(VOR)25,39925,39903324530.29%+121
REGENERON PHARMACEUTICALS(REGN)4,1904,19003,2343,2372.05%+3
BIOHAVEN LTD(BHVN)513,184563,184+50,0005,7944,7653.02%-1,029
INNOVIVA INC(INVA)2,816,0222,130,950-685,07256,29249,65131.50%-6,641
CYTOKINETICS INC(CYTK)396,357228,623-167,73425,18515,0699.56%-10,116
IRONWOOD PHARMACEUTICALS INC(IRWD)15,919,4359,188,635-6,730,80053,64832,25220.46%-21,396
NEUROCRINE BIOSCIENCES INC(NBIX)303,151116,533-186,61842,99615,3529.74%-27,644
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q1 2026 | TickerTrail